• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT STAT TROPONIN-I REAGENT KIT; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT STAT TROPONIN-I REAGENT KIT; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Model Number 2K41-27
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/24/2021
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed a false negative architect stat troponin-i result for one patient.The initial architect stat troponin-i result on (b)(6) 2021 was 1.72 ng/ml, auto retest auto validated as 0.01 ng/ml.The 0.01 ng/ml result was reported to physician.The sample was repeated, and the result was 1.72 ng/ml (true high/critical result).For investigation/troubleshooting purposes, the customer repeated the patient's sample with plasma (green top) and the results were high as well (no specific value provided).No adverse impact to patient management was reported.
 
Manufacturer Narrative
A ticket search for lot 30327un21 did not identify an increase complaint activity related to the falsely depressed patient results.A review of ticket trending data for the architect stat troponin-i (ln 2k41) was performed.Trending review did not identify any trends for the complaint issue.Device history record review did not identify any issues associated with lot 30327un21 and the complaint issue.Historical performance of the lot 30327un21 was reviewed using worldwide field data.The patient median data (divided into 3 groups) and cal f rlu mean were analyzed and compared to an established control limit.This evaluation indicated that all three levels of the patient medians and the cal f rlu mean for the lot 30327un21 are within the established limits.Therefore, no unusual reagent lot performance was identified for the lot 30327un21.Labeling was reviewed and found to adequately address the customer issue falsely depressed patient results.Based on the investigation, no systemic issue or deficiency of the architect stat troponin-i reagent lot 30327un21 was identified corrected data found in section d3 and section g1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT STAT TROPONIN-I REAGENT KIT
Type of Device
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064
Manufacturer (Section G)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford, IL N39 E-932
2246682940
MDR Report Key12639725
MDR Text Key281922306
Report Number1415939-2021-00041
Device Sequence Number1
Product Code MMI
UDI-Device Identifier00380740048525
UDI-Public00380740048525
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K041192
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2022
Device Model Number2K41-27
Device Catalogue Number02K41-27
Device Lot Number30327UN21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/27/2021
Initial Date FDA Received10/15/2021
Supplement Dates Manufacturer Received01/10/2022
Supplement Dates FDA Received01/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/31/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I1000SR INTGR, 01L86-40, (B)(6); ARC I1000SR INTGR, 01L86-40, (B)(6)
-
-